Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hayes

Showing results (521-530 of 696) with videos related to

Pageof 70
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5Xiao-Ying Hua, Carol S Hayes, Anthony Hofer, et al.
Endocrinology|April 1, 1988
Inability of a mouse cell line transformed to produce biologically active recombinant human insulin-like growth factor I (IGF-I) to respond to exogenously added IGF-IM A Cascieri, N S Hayes, B Kelder, et al.
Journal of Clinical Microbiology|July 1, 1984
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzaeG W Ajello, J C Feeley, P S Hayes, et al.
Structure (London, England : 1993)|March 25, 2014
CdiA from Enterobacter cloacae delivers a toxic ribosomal RNase into target bacteriaChristina M Beck, Robert P Morse, David A Cunningham, et al.
Mbio|February 3, 2021
Genetic Evidence for SecY Translocon-Mediated Import of Two Contact-Dependent Growth Inhibition (CDI) ToxinsAllison M Jones, Petra Virtanen, Disa Hammarlöf, et al.
Current Biology : CB|August 9, 2011
piRNA production requires heterochromatin formation in DrosophilaPrashanth Rangan, Colin D Malone, Caryn Navarro, et al.
AJR. American Journal of Roentgenology|August 1, 1991
MR imaging of the portal venous system: value of gradient-echo imaging as an adjunct to spin-echo imagingP M Silverman, R H Patt, B S Garra, et al.
Plos One|March 19, 2015
Genetic analysis of the CDI pathway from Burkholderia pseudomallei 1026bSanna Koskiniemi, Fernando Garza-Sánchez, Natasha Edman, et al.
Journal of Pharmacological and Toxicological Methods|June 30, 2024
Innovative approaches to cardiovascular safety pharmacology assessmentMichael K Pugsley, Brett R Winters, Yevgeniya E Koshman, et al.
Circulation Research|October 1, 1981
Factors influencing vascular hyporesponsiveness to angiotensin IIR Adamick, M E Gold, S Hayes, et al.
Pageof 70

Showing results (521-530 of 696) with videos related to

Sort By:
Pageof 70
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5Xiao-Ying Hua, Carol S Hayes, Anthony Hofer, et al.
Endocrinology|April 1, 1988
Inability of a mouse cell line transformed to produce biologically active recombinant human insulin-like growth factor I (IGF-I) to respond to exogenously added IGF-IM A Cascieri, N S Hayes, B Kelder, et al.
Journal of Clinical Microbiology|July 1, 1984
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzaeG W Ajello, J C Feeley, P S Hayes, et al.
Structure (London, England : 1993)|March 25, 2014
CdiA from Enterobacter cloacae delivers a toxic ribosomal RNase into target bacteriaChristina M Beck, Robert P Morse, David A Cunningham, et al.
Mbio|February 3, 2021
Genetic Evidence for SecY Translocon-Mediated Import of Two Contact-Dependent Growth Inhibition (CDI) ToxinsAllison M Jones, Petra Virtanen, Disa Hammarlöf, et al.
Current Biology : CB|August 9, 2011
piRNA production requires heterochromatin formation in DrosophilaPrashanth Rangan, Colin D Malone, Caryn Navarro, et al.
AJR. American Journal of Roentgenology|August 1, 1991
MR imaging of the portal venous system: value of gradient-echo imaging as an adjunct to spin-echo imagingP M Silverman, R H Patt, B S Garra, et al.
Plos One|March 19, 2015
Genetic analysis of the CDI pathway from Burkholderia pseudomallei 1026bSanna Koskiniemi, Fernando Garza-Sánchez, Natasha Edman, et al.
Journal of Pharmacological and Toxicological Methods|June 30, 2024
Innovative approaches to cardiovascular safety pharmacology assessmentMichael K Pugsley, Brett R Winters, Yevgeniya E Koshman, et al.
Circulation Research|October 1, 1981
Factors influencing vascular hyporesponsiveness to angiotensin IIR Adamick, M E Gold, S Hayes, et al.
Pageof 70